диссертации / 84
.pdf238.Jeong, S-Kl. Does waist indicate dyslipidemia better than BMI in Korean adult population? /Jeong S-K, Seo M-W, Kim Y-H, et al. //J Korean Med Sci. - 2005. -№20.-Р.7–12.
239.Johnson, B. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease/Johnson BD, Shaw LJ, Buchthal SD, et al. //Circulation. - 2004. -№ 109. -Р.2993 – 2999.
240.Johnson, B. The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles atherosclerosis study/Johnson BD, Dwyer KM, Stanczyk FZ, et al.// J Clin Endocrinol Metab. - 2010. -№95. -
Р.4432–4440.
241. Juonala, M. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium / M. Juonala, C.G. Magnussen, A. Venn, et al.// Circulation. - 2010. -№122 (24). -
Р.2514–20.
242.Kanai, H. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women/Kanai H., Tokunaga K., Fujioka S., et al.// Hypertension. - 1996. -№ 27(1). -Р.125–9.
243.Kanaya, A., Grady, D, Barrett-Connor, E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis//Arch Intern Med. - 2002. -№162. -Р.1737 – 1745.
244.Kang, Y.S. Obesity Associated Hypertension: New Insights into Mechanism // Electrolyte Blood Press. - 2013. -№11 (2). -Р. 46–52.
245.Kannel, W. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study/Kannel WB, Castelli WP, Gordon T, et al.// Ann Intern Med. - 1971. -№74. -Р.1–12.
261
246.Kannel, WB. Blood pressure as a cardiovascular risk factor: prevention and treatment//JAMA 1996. - №275. - Р.1571 – 1576.
247.Kardassis, D. Carotid artery remodelling in relation to body fat distribution, inflammation and sustained weight loss in obesity/Kardassis D,
Schönander M, Sjöström L, et al.// J Intern Med.- 2014. -275(5). -P.534-43.
248.Kardys, I. The female advantage in cardiovascular disease: do vascular beds contribute equally? /Kardys I, Vliegenthart R, Oudkerk M, et al. //Am J Epidemiol. - 2007. -№166. -Р.403 – 412.
249.Karim, R. Association of Endogenous Sex Hormones with Adipokines and Ghrelin in Postmenopausal Women. /Karim R, Stanczyk FZ, Brinton RD, et al. // J Clin Endocrinol Metab. - 2014. -№ 18. - jc20141839.
250.Katzmarzyk, P. Sitting time and mortality from all causes, cardiovascular disease, and cancer /Katzmarzyk PT, Church TS, Craig CL, et al.// Med Sci Sports Exerc. - 2009. -№41(5). -Р.998-1005.
251.Kaul, S. Thiazolidinedione drugs and cardiovascular risk: a science advisory from the American Heart Association and American College of Cardiology foundation /S. Kaul, A.F. Bolger, D.Herrington, et al. // J Am Coll Cardiol. - 2010. -№55. -Р.1885–1894.
252.Kawachi, I. Smoking cessation in relation to total mortality rates in women. A prospective cohort study / Kawachi I, Colditz GA, Stampfer MJ, et al.// Ann Intern Med. - 1993. -№119. -Р.992 – 1000.
253.Keys, A. The seven countries study: 2,289 deaths in 15 years / Keys A, Menotti A, Aravanis C, et al. // Prev Med. - 1984. -№13(2). -Р.141–154.
254.Kim, J. Recent changes in cardiovascular risk factors among women and men / Kim JK, Alley D, Seeman T, et al. // J Womens Health (Larchmt). - 2006. -№15 ._Р.734 – 746.
255.Klop, B., Elte, J. W., Cabezas, M. C. Dyslipidemia in Obesity: Mechanisms and Potential Targets//Nutrients. - 2013. -№ 5. -Р.1218-40.
262
256.Kodama, S. Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis /Kodama S, Horikawa C, Fujihara K, et al.// Obes Rev. - 2014- №15(3). - С.202-14.
257.Kolber, M.R. Family history of cardiovascular disease//Canadian Family Physician. - 2014. -№60.-Р.1016
258.Kones, R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey// Drug Design, Development and Therapy. - 2011. -№5. - Р.325–380.
259.Koskinen, J. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young
adults: the cardiovascular risk in young Finns study/Koskinen J, Kähönen M,
Viikari J, et al.//Circulation. - 2009. -№ 21. - 120(3). -Р.229-36.
260. Kotseva, K. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I,II, and III surveys in eight European countries/Kotseva K, Wood D, De Backer G, et al.// Lancet. -2009. -№373. -
Р.929–940.
261.Kotseva, K. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries/Kotseva K, Wood D, De Backer G, et al. // Eur J Cardiovasc Prev Rehabil. - 2010. -№17. -Р.530 – 540.
262.Kotseva, K. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries/Kotseva K, Wood D, De Backer G, et al.// Eur J Cardiovasc Prev Rehabil. - 2009. -№16. -Р.121 – 137.
263.Kramer, M. The double jeopardy of clustered measurement and cluster randomisation /Kramer MS, Martin RM, Sterne JA, et al.//BMJ. - 2009. -
№339. -Р.b2900.
264.Kruk, M. Intravascular ultrasonic study of gender differences in
ruptured coronary plaque morphology and its associated clinical
263
presentation/Kruk M, Pregowski J, Mintz GS, et al.// Am J Cardiol. - 2007. -
№100. -Р.185 – 9.
265.LaBrecque, D. Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: World Gastroenterology Organisation Global Guidelines 2012 / LaBrecque D., Abbas Z., Anania F., et al. //- World Gastroenterology Organisation, 2012. - 29p.
266.Lafontan, M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans/Lafontan M., Moro C., Sengenes C., et al.// Arterioscler Thromb Vasc Biol. - 2005. -№25. -Р.2032–42.
267.Lanza, GA, Crea, F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management//Circulation. - 2010. -№121. -Р.2317 – 2325
268.Lautala, P. Atherosclerosis precursors in Finnich children and adolescents. Serum immunoreactive insulin / Lautala P., Akerblom H.K., Vikari J. et al. // Acta Paediatr. Scand. - 1985. - Vol.318. - P.127-133.
269.Lee, CJ, Park, S. The Role of Carotid Ultrasound for Cardiovascular Risk Stratification beyond Traditional Risk Factors// Yonsei Med J.. -2014. -
№ 55(3). -Р.551–7.
270.Lee, D. Differential associations of weight dynamics with coronary artery calcium versus common carotid artery intima-media thickness: The CARDIA Study / Lee DH, Steffes MW, Gross M, et al. //Am J Epidemiol. - 2010.-№ 15. -Vol.172 (2)- P-180-9.
271.Lee, S., Kwak, HB. Role of adiponectin in metabolic and cardiovascular disease // Journal of Exercise Rehabilitation. - 2014. -№10(2). -Р.54-59.
272.Legro, R. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline/Legro RS, Arslanian SA, Ehrmann DA, et al. // J Clin Endocrinol Metab.-2013.-№ 98.-Р.4565–4592.
273.Leifheit-Limson, E. The role for social support in health status and depressive symptoms after acute myocardial infarction: evidence for a
264
stronger relationship among women/Leifheit-Limson EC, Reid KJ, Kasl SV,
et al.// Circ Cardiovasc Qual Outcomes. - 2010. -№ 3. -Р.143 – 150.
274.Lemieux, C, Cloutier, I, Tanguay, JF. Menstrual cycle influences endothelial progenitor cell regulation: a link to gender differences in vascular protection? // Int J Cardiol. - 2009. -№136.-Р.200 – 210.
275.Leonardo, F. Effect of acute administration of estradiol 17 beta on aortic blood flow in menopausal women / Leonardo F, Medeirus C, Rosano GM, et al. //Am J Cardiol/ - 1997/ -№80. -Р.791 – 793.
276.Lerchbaum, E. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method/ Lerchbaum E, Schwetz V, Giuliani A, et al. //Hum Reprod. -2013. -№28.- Р.2537–44.
277.Lerchbaum, E. Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype/Lerchbaum E, Schwetz V, Rabe T, et al.//PLoS ONE. - 2014. -№ 9(10): e108263.
278.Lerchbaum, E. Hypertriglyceridemic waist is associated with impaired glucose tolerance in polycystic ovary syndrome//Nutr Metab Cardiovasc Dis. - 2013. -№23. -Р.e15–16.
279.Lerchbaum, E. Opposing effects of DHEAS and free testosterone on metabolic phenotype in women with polycystic ovary syndrome/Lerchbaum E, Schwetz V, Giuliani A, et al.//Fertil Steril. - 2012.-№98. -Р.1318–1325.
280.Levy, D. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study/Levy D, Garrison RJ, Savage DD, et al.//N Engl J Med. - 1990.-№322. -Р.1561–6.
281.Li, C. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study/Li C, Engstrom G, Hedblad B, et al.// Int J Obes (Lond). - 2006. -№30. -Р.1775 –
1781.
265
282.Lindström, J, Louheranta, A, Mannelin, M. The Finnish Diabetes
Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and
physical activity // Diabetes Care. - 2003. - №26. - Р.3230-6.
283.Lloyd-Jones, D. Heart disease and stroke statistics—2010 update: a report from the American Heart Association/Lloyd-Jones D, Adams RJ, Brown TM, et al. // Circulation. - 2010. -№121. - e46 – e215.
284.Lo, J. Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women / Lo J, Dolan SE, Kanter JR, et al. // J Clin Endocrinol Metab. - 2006. -№91(5). - Р.1677-82.
285.Lohman, T. Anthoropometric Standardization Reference Manual / Lohman TG, Roche AF, Martorell R, et al. - Champaign, IL: Human Kinetics Books; 1998.-211р.
286.Lorenz, M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis / Lorenz M, Markus HS, Bots ML, et al.//Circulation. - 2007. - № 30. -Vol.115(4). -Р.459- 67.
287.Maas, А. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in women/Maas А., van der Schouw Y., Regitz-Zagrosek V., et al. //European Heart Journal.-2011. -№32. -
Р.1362–1368
288.Macut, D, Antić, IB, Bjekić-Macut, J. Cardiovascular risk factors and events in women with androgen excess// J Endocrinol Invest.- 2014.
289.Magnussen, E. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors/Magnussen EB, Vatten LJ, Smith GD, et al. // Obstet Gynaecol. - 2009. -№114. -Р.961–70.
290.Maliqueo, M. Relationship between leptin and insulin sensitivity in
patients with polycystic ovary syndrome /Maliqueo M, Pérez-Bravo F,
Calvillán M, et al. //Med Clin (Barc). - 1999. -№113. -Р. 526–30.
266
291.Manolio, T. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop/Manolio TA, Pearson TA, Wenger NK, et al.//Ann Epidemiol. -1992. -№2. -Р.161 – 176.
292.Manson, JE. A prospective study of obesity and risk of coronary heart disease in women/Manson JE, Colditz GA, Stampfer MJ, et al.//N Engl J Med. - 1990. -№322.-Р.882–9.
293.Manson, JE. Body weight and mortality among women/Manson JE, Willett WC, Stampfer MJ, et al. //N Engl J Med. - 1995. -№333. -Р.677–85.
294.McDonald, S. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analysis/McDonald SD, Malinowski A, Zhou Q, et al. // Am Heart J. - 2008. -№156. -Р.918–30.
295.McMurray, JJ. The NAVIGATOR Study Group Effect of valsartan on the incidence of diabetes and cardiovascular events /J. McMurray, R. Holman, S. Haffner, et al. // N Engl J Med. - 2010. -·№362(16). -Р.1477–1490.
296.Melloni, C. Representation of women in randomized clinical trials of cardiovascular disease prevention / Melloni C, Berger JS, Wang TY, et al.//Circ Cardiovasc Qual Outcomes. - 2010. -№3. -Р.135 – 142.
297.Mendelsohn, ME, Karas, RH. Molecular and cellular basis of cardiovascular gender differences // Science.- 2005. -№308. -Р.1583 – 1587.
298.Mendelsohn, ME, Karas, RH. The protective effect of estrogen on the cardiovascular system // N Engl J Med. - 1999. -№340. -Р.1801–1811.
299.Meyer, M. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis/Meyer ML, Malek AM, Wild RA, et al.// Hum Reprod Update. -2012.-№18(2). -Р.112-26.
300.Misichronis, G. The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia / Misichronis G, Georgopoulos NA, Marioli DJ, et al. //Gynecol Endocrinol. - 2012. -№28. -Р.249–252.
301.Moore, SC. Waist versus weight — which matters more for mortality? //Am J Clin Nutr. - 2009. -№89. -Р.1003–4.
267
302.Mora, S. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials /Mora S, Glynn RJ, Hsia J, et al.// Circulation. - 2010. -№121. -Р.1069 – 1077.
303.Mosca, L. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the
Аmerican Heart Association / Mosca L, Benjamin EJ, Berra K, et al. //
Circulation. - 2011. -№123. - Р.1243–62.
304.Mosca, L. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update/Mosca L, Banka CL, Benjamin EJ, et al. // Circulation. - 2007. - 115. -Р.1481 – 1501
305.Mosca, L. National study of physician awareness and adherence to cardiovascular disease prevention guidelines /Mosca L, Linfante AH, Benjamin EJ, et al.// Circulation. - 2005. -№111. -Р.499 – 510.
306.Mounier-Vehier, C. Heart, arteries and women, a care pathway for women at high cardiovascular risk / C. Mounier-Vehier, F. Boudghene, P. Delsart, et al. // Ann Cardiol Angeiol (Paris). – 2014. - №63(3). – Р.192-6.
307.Murray, C. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 / Murray CJ, Vos T, Lozano R., et al. // Lancet. - 2012. - №380. -Р. 2197–2223.
308.Nadas, J. Intraobserver and interobserver variability of measuring waist circumference /Nadas J, Putz Z, Kolev G, et al.// Med Sci Monit. - 2008. -
№14. -Р.CR15 – CR18.
309. Nascimbeni, F. From NAFLD in clinical practice to answers from guidelines / Nascimbeni F., Pais R., Bellentani S., et al. // Journal of Hepatology. - 2013. -№59. -Р.j 859–871
268
310.Neeland, I. Relation of regional fat distribution to left ventricular structure and function / Neeland IJ, Gupta S, Ayers CR, et al. //Circ Cardiovasc Imaging. 2013. -№6(5). -Р.800-7.
311.Ng, M. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 / Ng M, Fleming T, Robinson M, et al. // Lancet. - 2014. - № 384 (9945). -Р.766-81.
312.Nicholls, S. Rate of progression of coronary atherosclerotic plaque in women / Nicholls SJ, Wolski K, Sipahi I, et al. // J Am Coll Cardiol.- 2007. -
№49. -Р.1546 – 1551.
313.Nichols, M. European cardiovascular disease statistics 2012:European Society of Cardiology/Nichols M, Townsend N, Luengo-Fernandez R, et al. - Brussels:European Heart Network, Sophia Antipolis, 2012. -122р.
314.Nordhamn, K. Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables/ Nordhamn K, Sodergren E, Olsson E, et al. // Int J Obes Relat Metab Disord. - 2000. -№24. -Р.652 – 657.
315.Nugent, L. Gender and microvascular angina / Nugent L, Mehta PK, Bairey Merz CN. // J Thromb Thrombolysis. - 2011. -№31. -Р.37 – 46.
316.O’Donoghue, M. Early invasive versus conservative treatment
strategies in women and men with unstable angina and non-ST-elevation myocardial infarction: a meta-analysis /O’Donoghue M, Boden WE,
Braunwald E, et al. // JAMA. - 2008. -№300. -Р.71 – 80.
317. O’Reilly, M. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione / O’Reilly
MW, Taylor AE, Crabtree NJ, et al.//J Clin Endocrinol Metab. - 2014. -№ 99.
-Р.1027– 1036.
318. Obesity and overweight: Fact sheet N°311. - Geneva, World Health Organization Press, 2014. - 1p. [Электронный ресурс]. - Режим доступа:
269
http://www.who.int/mediacentre/factsheets/fs311/en/, свободный. - Загл. с экрана. - Яз. англ.
319. Ogden, C. Prevalence of overweight and obesity in the United States, 1999 – 2004 /Ogden CL, Carroll MD, Curtin LR, et al.// JAMA. - 2006. -
№295. -Р.1549 – 1555.
320.Orth-Gome,r K, Leineweber, C. Multiple stressors and coronary disease in women. The Stockholm female coronary risk study// Biol Psychol. - 2005. -№69. -Р.57–66.
321.Ossewaarde, M. Age at menopause, cause-specific mortality and total life expectancy / Ossewaarde ME, Bots ML, Verbeek AL, et al. // Epidemiology. - 2005. -№16. -№556–62.
322.Pare, G. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury/Pare G, Krust A, Karas RH, et al.// Circ Res. - 2002. -№90.-Р.1087 – 92.
323.Park, YS, Kim, J-S. Obesity phenotype and coronary heart disease risk as estimated by the Framingham risk score//J Korean Med Sci. - 2012. -№27.
-Р.243–9.
324.Pearson, L. Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II / Pearson L., Collins P, Rosano GM, Sarrel PM,et al. // Peptides. - 2008. -№29. -Р.1057 – 1061.
325.Pearson, T. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association/Pearson TA, Mensah GA, Alexander RW, et al.// Circulation. - 2003. -№107.- Р.499 – 511.
326.Peters, S. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review / Peters SA, den Ruijter HM, Bots ML, et al. // Heart. - 2012. - №98.
-Р.177–184.
270